Novavax Inc (NVAX.OQ)
NVAX.OQ on NASDAQ Stock Exchange Global Select Market
1.69USD
8:59pm GMT
1.69USD
8:59pm GMT
Change (% chg)
$-0.02 (-1.17%)
$-0.02 (-1.17%)
Prev Close
$1.71
$1.71
Open
$1.73
$1.73
Day's High
$1.79
$1.79
Day's Low
$1.68
$1.68
Volume
709,701
709,701
Avg. Vol
1,207,402
1,207,402
52-wk High
$2.75
$2.75
52-wk Low
$1.05
$1.05
About
Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates... (more)
Overall
| Beta: | 2.45 |
| Market Cap(Mil.): | $654.67 |
| Shares Outstanding(Mil.): | 382.85 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| NVAX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 81.01 | 29.57 |
| EPS (TTM): | -0.53 | -- | -- |
| ROI: | -79.33 | -0.53 | 12.77 |
| ROE: | -- | -3.22 | 14.47 |
Estimates